These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16998755)

  • 1. Therapy of immune neuropathies with intravenous immunoglobulins.
    Gold R; Kieseier BC
    J Neurol; 2006 Sep; 253 Suppl 5():V59-63. PubMed ID: 16998755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Immunoglobulin in the Treatment of Immune-Mediated Peripheral Neuropathies.
    Tobon A
    J Infus Nurs; 2017; 40(6):375-379. PubMed ID: 29112586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immunoglobulins in the treatment of immune neuropathies.
    Kieseier BC; Meyer Zu Hörste G; Lehmann HC; Gold R; Hartung HP
    Curr Opin Neurol; 2008 Oct; 21(5):555-62. PubMed ID: 18769249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin Treatment in Neuromuscular Medicine.
    Burakgazi AZ
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):182-193. PubMed ID: 31135621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.
    Abbas A; Rajabally YA
    Curr Drug Saf; 2019; 14(1):3-13. PubMed ID: 30332974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospect of novel therapies in immune-mediated neuropathies].
    Kuwahara M
    Rinsho Shinkeigaku; 2024 Jan; 64(1):1-7. PubMed ID: 38072443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies.
    Dalakas MC
    Neurology; 2002 Dec; 59(12 Suppl 6):S13-21. PubMed ID: 12499466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange in immune-mediated neuropathies.
    Lehmann HC; Hartung HP; Meyer Zu Hörste G; Kieseier BC
    Curr Opin Neurol; 2008 Oct; 21(5):547-54. PubMed ID: 18769248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R; Pashenkov M; Jin JP; Link H
    J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of idiopathic inflammatory neuropathies.
    Donofrio PD
    Muscle Nerve; 2003 Sep; 28(3):273-92. PubMed ID: 12929187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory neuropathies.
    Briemberg HR; Amato AA
    Curr Neurol Neurosci Rep; 2005 Feb; 5(1):66-71. PubMed ID: 15676111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune-mediated neuropathies.
    Kiefer R; Kieseier BC; Hartung HP
    Adv Neurol; 2002; 88():111-31. PubMed ID: 11908221
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H; Straver DC
    Muscle Nerve; 2014 Jan; 49(1):4-20. PubMed ID: 24037667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
    Iannaccone S; Sferrazza B; Quattrini A; Smirne S; Ferini-Strambi L
    Neurology; 1999 Sep; 53(5):1154-5. PubMed ID: 10496291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.